Labcorp

LH Net selling

CIK 0000920148 #284 in the set updated 17 Sep 2026

Bought (120 mo)

$1.04M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$175.44M

$18.90M on a plan · $105.33M straight out of an exercise

Sold at will

$51.21M

114 of 210 sales

Net

−$174.40M

−$50.17M against sales at will

By person

36 insiders · 219 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

KING DAVID P

Director

—

$63.14M (15) scheduled

−$63.14M

344,155

0.4244%

$109.45M

+77.8%

EISENBERG GLENN A

Executive Vice President

—

$34.20M (27) scheduled

−$34.20M

37,920

0.0468%

$12.06M

+358.6%

Schechter Adam H

President & CEO

—

$14.69M (10) scheduled

−$14.69M

102,565

0.1265%

$32.62M

+2,192%

van der Vaart Sandra D

EVP, Corporate Affairs

—

$8.53M (33) scheduled

−$8.53M

6,239

0.0077%

$1.98M

+368.6%

ANDERSON KERRII B

Director

—

$7.56M (19) scheduled

−$7.56M

6,563

0.0081%

$2.09M

−62.5%

Schroeder Mark S

EVP, Pres Diagnostics & COO

—

$7.42M (22) scheduled

−$7.42M

12,677

0.0156%

$4.03M

+1,951%

BELINGARD JEAN-LUC

Director

—

$6.41M (4) scheduled

−$6.41M

17,781

0.0219%

$5.65M

−41.8%

BERBERIAN LANCE

EVP, Special Advisor, Strategy

—

$5.28M (6)

−$5.28M

18,652

0.0230%

$5.93M

+1,436%

EBERTS F SAMUEL III

Chief Legal Officer, Secretary

—

$4.89M (1) scheduled

−$4.89M

28,823

0.0355%

$9.17M

+59.5%

Kirchgraber Paul R

CEO, Covance Drug Development

—

$3.95M (4) scheduled

−$3.95M

12,946

0.0160%

$4.12M

+193.8%

Wilkinson Peter J

SVP, Chief Accounting Officer

—

$3.73M (15) scheduled

−$3.73M

1,770

0.0022%

$562.97K

+1,270%

Dodson Edward T

Principal Accounting Officer

—

$2.84M (3) scheduled

−$2.84M

13,663

0.0168%

$4.35M

+311.3%

Uthgenannt Lisa J

Chief Human Resources Officer

—

$2.69M (4)

−$2.69M

4,660

0.0057%

$1.48M

+23.3%

Summy Amy B.

EVP, Chief Marketing Officer

—

$2.27M (7) scheduled

−$2.27M

6,956

0.0086%

$2.21M

—

Parham Richelle P

Director

—

$1.78M (1)

−$1.78M

3,366

0.0042%

$1.07M

—

Williams R Sanders

Director

—

$1.47M (11)

−$1.47M

8,120

0.0100%

$2.58M

+50.0%

MITTELSTAEDT ROBERT E JR

Director

—

$1.37M (6) scheduled

−$1.37M

15,515

0.0191%

$4.93M

+36.7%

Gilliland Dwight Gary

Director

—

$1.30M (11)

−$1.30M

6,656

0.0082%

$2.12M

+128.6%

NEUPERT PETER M

Director

$922.82K (3)

—

+$922.82K

13,784

0.0170%

$4.38M

—

Caveney Brian J

EVP, Pres of BLS, CMO & CSO

$20.42K (2)

$923.46K (2)

−$903.03K

36,492

0.0450%

$11.61M

+3,767%

Meltzer Jonathan C

EVP, COO

—

$298.76K (4) scheduled

−$298.76K

3,620

0.0045%

$1.15M

+43.8%

Gary M. Huff

CEO, LabCorp Diagnostics

—

$293.82K (1)

−$293.82K

1,850

0.0023%

$588.21K

+359.4%

Kyle Kathryn W

EVP, Chief Legal Officer

—

$227.41K (2) scheduled

−$227.41K

3,904

0.0048%

$1.24M

+27.9%

DiVincenzo Jonathan P.

EVP, Pres, Central Labs & Intl

—

$107.75K (1)

−$107.75K

5,461

0.0067%

$1.74M

+65.0%

Seltz Judith C

EVP, CHRO

$99.36K (2)

—

+$99.36K

4,182

0.0052%

$1.33M

+1,075%

Vaughn Bryan T

EVP and President, Diagnostics

—

$66.97K (1) scheduled

−$66.97K

6,746

0.0083%

$2.15M

+31.1%

Ratliff John D

CEO, Covance Drug Development

—

—

—

16,941

0.0209%

$5.39M

—

Kong Garheng

Director

—

—

—

13,739

0.0169%

$4.37M

+308.4%

Davis Jeffrey A.

Director

—

—

—

5,460

0.0067%

$1.74M

—

GRAHAM ANITA Z

EVP, CHRO

—

—

—

5,185

0.0064%

$1.65M

+17,183%

Oyegunwa Akinbolade

EVP, CIO & CTO

—

—

—

5,064

0.0062%

$1.61M

+89.9%

Bailey Megan D.

EVP, Pres, Central Labs & Intl

—

—

—

4,851

0.0060%

$1.54M

+3,876%

Wengel Kathryn E

Director

—

—

—

4,133

0.0051%

$1.31M

—

Kliphouse Kirsten Marie

Director

—

—

—

3,160

0.0039%

$1.00M

—

Rothman Paul

Director

—

—

—

2,571

0.0032%

$817.63K

+19,677%

Wang Julia Aijun

Chief Financial Officer, EVP

—

—

—

1,817

0.0022%

$577.92K

+29,027%

Individual transactions

7

Insider

Date

Role

Action

Shares

Price

Amount

Caveney Brian J

7 Sep 2022

EVP, President of Diagnostics

Buy

44

$231.20

$10.25K

Caveney Brian J

7 Jun 2022

EVP, President of Diagnostics

Buy

42

$242.19

$10.17K

NEUPERT PETER M

16 Feb 2022

Director

Buy

600

$264.57

$158.74K

NEUPERT PETER M

16 Feb 2022

Director

Buy

1,600

$263.98

$422.37K

NEUPERT PETER M

16 Feb 2022

Director

Buy

1,300

$262.85

$341.71K

Seltz Judith C

10 Mar 2020

EVP, CHRO

Buy

330

$168.56

$55.62K

Seltz Judith C

28 Feb 2020

EVP, CHRO

Buy

250

$174.94

$43.74K

Show all 219 transactions →

What was left out

Form 4 filings counted 732

Amendments (4/A) skipped 2

Filings about a different issuer 1

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 35

Sales straight out of an exercise 61

Sales at will 114

Transactions with no price 0

Shares from compensation/vesting 2,552,387

Sales filed before the plan box existed 84

History held since 7 Sep 2016